REMDESIVIR

REMDESIVIR was reported 13295 times

REMDESIVIR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLINICAL TRIAL PARTICIPANT 21 0.3684
1 MASKED FEVER 5 0.3571
2 PULMONARY TRICHOSPORONOSIS 8 0.3478
3 COVID-19 TREATMENT 21 0.3088
4 MITRAL PERFORATION 4 0.2500
5 SARS-COV-2 VIRAEMIA 12 0.2069
6 LACTOBACILLUS BACTERAEMIA 4 0.1905
7 SARS-COV-2 RNA INCREASED 11 0.1618
8 PARAVENOUS DRUG ADMINISTRATION 6 0.1395
9 COINFECTION 9 0.1304
10 RHINOCEREBRAL MUCORMYCOSIS 39 0.1124
11 CRYPTOCOCCAL MENINGOENCEPHALITIS 13 0.0992
12 PNEUMONIA SERRATIA 4 0.0870
13 CUTANEOUS MUCORMYCOSIS 15 0.0815
14 BRONCHOPLEURAL FISTULA 29 0.0771
15 ISOSPORIASIS 6 0.0769
16 HEPATIC AMOEBIASIS 5 0.0746
17 OCULOAURICULOVERTEBRAL DYSPLASIA 5 0.0694
18 PULMONARY MUCORMYCOSIS 36 0.0682
19 LUNG ASSIST DEVICE THERAPY 4 0.0645
20 BORDETELLA INFECTION 5 0.0556
21 RENAL REPLACEMENT THERAPY 7 0.0547
22 MESENTERIC HAEMORRHAGE 4 0.0465
23 AMOEBIC COLITIS 4 0.0440
24 NATURAL KILLER CELL COUNT DECREASED 4 0.0435
25 HUMORAL IMMUNE DEFECT 16 0.0431
26 COVID-19 PNEUMONIA 505 0.0427
27 MYCOTIC ENDOPHTHALMITIS 8 0.0423
28 GASTROINTESTINAL MUCORMYCOSIS 7 0.0419
29 HERPES SIMPLEX REACTIVATION 15 0.0394
30 DRUG RESISTANCE MUTATION 7 0.0393
31 PNEUMOMEDIASTINUM 71 0.0392
32 CEREBRAL NOCARDIOSIS 9 0.0386
33 DISSEMINATED ASPERGILLOSIS 18 0.0381
34 PULMONARY NECROSIS 12 0.0352
35 CRYPTOCOCCAL FUNGAEMIA 5 0.0350
36 INTESTINAL BARRIER DYSFUNCTION 4 0.0345
37 ACQUIRED MACROGLOSSIA 3 0.0337
38 SUBCUTANEOUS EMPHYSEMA 33 0.0336
39 BAROTRAUMA 3 0.0326
40 MUCORMYCOSIS 84 0.0323
41 HAEMORRHAGIC CHOLECYSTITIS 4 0.0320
42 DISSEMINATED STRONGYLOIDIASIS 7 0.0320
43 PNEUMONIA CRYPTOCOCCAL 30 0.0317
44 DIVERTICULITIS INTESTINAL PERFORATED 11 0.0308
45 DISSEMINATED MUCORMYCOSIS 12 0.0305
46 ASPERGILLUS TEST POSITIVE 9 0.0292
47 DISSEMINATED CRYPTOCOCCOSIS 22 0.0291
48 CYSTIC LUNG DISEASE 4 0.0282
49 MYOPATHY TOXIC 17 0.0275
50 ACINETOBACTER BACTERAEMIA 5 0.0266
51 BRONCHOPULMONARY ASPERGILLOSIS 206 0.0265
52 PULMONARY AIR LEAKAGE 4 0.0265
53 SUPERINFECTION BACTERIAL 21 0.0265
54 HAEMOFILTRATION 5 0.0263
55 SPONTANEOUS BACTERIAL PERITONITIS 6 0.0246
56 BURKHOLDERIA TEST POSITIVE 3 0.0242
57 INFECTION REACTIVATION 27 0.0236
58 ACUTE RIGHT VENTRICULAR FAILURE 4 0.0235
59 CYTOKINE STORM 16 0.0234
60 ISCHAEMIC HEPATITIS 32 0.0234
61 CHEST WALL HAEMATOMA 6 0.0233
62 B-CELL APLASIA 6 0.0233
63 POST-ACUTE COVID-19 SYNDROME 28 0.0226
64 INFUSION SITE EXTRAVASATION 136 0.0218
65 MONOCYTE PERCENTAGE DECREASED 4 0.0217
66 RECALLED PRODUCT 37 0.0214
67 AMOEBIASIS 5 0.0213
68 JEJUNAL PERFORATION 5 0.0207
69 PULMONARY CAVITATION 18 0.0207
70 PNEUMOTHORAX SPONTANEOUS 14 0.0206
71 VACCINATION FAILURE 34 0.0204
72 CRYPTOCOCCOSIS 33 0.0202
73 EOSINOPHIL PERCENTAGE DECREASED 4 0.0201
74 DIFFUSE ALVEOLAR DAMAGE 23 0.0200
75 CARDIAC ASTHMA 3 0.0200
76 PNEUMONIA STAPHYLOCOCCAL 39 0.0197
77 LIVER FUNCTION TEST INCREASED 422 0.0196
78 VACCINE INTERACTION 6 0.0194
79 GEOTRICHUM INFECTION 4 0.0190
80 BACTERIAL ENDOPHTHALMITIS 5 0.0188
81 STENOTROPHOMONAS INFECTION 25 0.0184
82 PULMONARY NOCARDIOSIS 15 0.0182
83 FUNGAEMIA 28 0.0178
84 HAEMOPERITONEUM 14 0.0175
85 PULSELESS ELECTRICAL ACTIVITY 73 0.0175
86 APGAR SCORE LOW 22 0.0171
87 PNEUMONIA NECROTISING 11 0.0170
88 PNEUMONIA PSEUDOMONAL 26 0.0169
89 CORYNEBACTERIUM INFECTION 9 0.0168
90 CANDIDA TEST POSITIVE 7 0.0167
91 PURPURA FULMINANS 4 0.0157
92 RETROPERITONEAL HAEMATOMA 34 0.0154
93 ALANINE AMINOTRANSFERASE INCREASED 935 0.0152
94 PRIMARY BILIARY CHOLANGITIS 7 0.0149
95 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 12 0.0146
96 CYTOMEGALOVIRUS ENTEROCOLITIS 11 0.0143
97 MECHANICAL VENTILATION 27 0.0142
98 CEREBRAL FUNGAL INFECTION 4 0.0141
99 BURKHOLDERIA CEPACIA COMPLEX INFECTION 4 0.0140
100 VASOGENIC CEREBRAL OEDEMA 10 0.0139
101 PERIOSTITIS 6 0.0139
102 PNEUMONIA BACTERIAL 124 0.0135
103 SINUS BRADYCARDIA 129 0.0133
104 FUNGAL ENDOCARDITIS 4 0.0133
105 HUMAN HERPESVIRUS 8 INFECTION 8 0.0131
106 ASPERGILLUS INFECTION 86 0.0131
107 CEREBRAL ASPERGILLOSIS 8 0.0130
108 FIBRIN D DIMER INCREASED 45 0.0126
109 TRANSIENT TACHYPNOEA OF THE NEWBORN 5 0.0126
110 SARS-COV-2 ANTIBODY TEST NEGATIVE 6 0.0125
111 PALLIATIVE CARE 19 0.0124
112 PNEUMONIA CYTOMEGALOVIRAL 24 0.0123
113 SPUTUM CULTURE POSITIVE 10 0.0123
114 SPLENIC ABSCESS 5 0.0123
115 BRADYCARDIA 652 0.0123
116 ALLERGIC RESPIRATORY SYMPTOM 4 0.0120
117 EXTRAVASATION 49 0.0119
118 ASPARTATE AMINOTRANSFERASE INCREASED 629 0.0118
119 PNEUMOCOCCAL INFECTION 7 0.0118
120 RETROPERITONEAL HAEMORRHAGE 29 0.0117
121 PROPOFOL INFUSION SYNDROME 8 0.0113
122 MUSCLE ABSCESS 7 0.0112
123 BONE INFARCTION 5 0.0110
124 INTERLEUKIN LEVEL INCREASED 6 0.0109
125 HAEMATOMA MUSCLE 13 0.0108
126 INFUSION SITE OEDEMA 9 0.0108
127 ENCEPHALOMALACIA 6 0.0107
128 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 4 0.0105
129 ACUTE RESPIRATORY DISTRESS SYNDROME 186 0.0105
130 INFECTIOUS PLEURAL EFFUSION 16 0.0105
131 HYPERBILIRUBINAEMIA NEONATAL 6 0.0103
132 CARDIAC VALVE VEGETATION 5 0.0103
133 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 5 0.0103
134 HYPERTRANSAMINASAEMIA 71 0.0102
135 HAEMOPHILUS INFECTION 10 0.0102
136 BLOOD FIBRINOGEN INCREASED 8 0.0101
137 RENAL TRANSPLANT FAILURE 10 0.0101
138 NECROTISING OESOPHAGITIS 5 0.0100
139 TRICHOSPORON INFECTION 4 0.0099
140 OPPORTUNISTIC INFECTION 18 0.0097
141 GLOMERULAR FILTRATION RATE INCREASED 8 0.0097
142 AMNIOTIC CAVITY INFECTION 7 0.0097
143 GLOMERULAR FILTRATION RATE DECREASED 117 0.0095
144 CREATININE RENAL CLEARANCE INCREASED 7 0.0094
145 CHORIORETINITIS 6 0.0093
146 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 7 0.0093
147 KLEBSIELLA INFECTION 47 0.0093
148 BLOOD GASES ABNORMAL 5 0.0093
149 CONTINUOUS HAEMODIAFILTRATION 9 0.0092
150 SYSTEMIC CANDIDA 23 0.0092
151 ADMINISTRATION SITE EXTRAVASATION 9 0.0090
152 RENAL INFARCT 13 0.0090
153 REFUSAL OF TREATMENT BY RELATIVE 4 0.0088
154 PELVIC ABSCESS 10 0.0087
155 ENTEROCOCCAL INFECTION 42 0.0087
156 INFANTILE APNOEA 7 0.0086
157 ACUTE RESPIRATORY FAILURE 165 0.0086
158 PROCALCITONIN INCREASED 10 0.0085
159 NEONATAL RESPIRATORY DISTRESS 8 0.0085
160 ORGANISING PNEUMONIA 42 0.0085
161 PNEUMOTHORAX 134 0.0084
162 BRADYCARDIA FOETAL 7 0.0084
163 ENTEROBACTER INFECTION 14 0.0083
164 CREATININE RENAL CLEARANCE DECREASED 33 0.0082
165 MULTIPLE ORGAN DYSFUNCTION SYNDROME 233 0.0082
166 PNEUMONIA KLEBSIELLA 15 0.0082
167 TRANSAMINASES INCREASED 178 0.0080
168 NECROTISING RETINITIS 5 0.0078
169 BLOOD MAGNESIUM INCREASED 7 0.0078
170 SINUS ARREST 12 0.0076
171 LUNG ABSCESS 16 0.0076
172 PREMATURE DELIVERY 121 0.0076
173 RESPIRATORY FAILURE 552 0.0076
174 HYPOXIA 261 0.0074
175 CENTRAL SEROUS CHORIORETINOPATHY 5 0.0073
176 PNEUMONIA STREPTOCOCCAL 8 0.0073
177 MARASMUS 11 0.0072
178 PNEUMONIA VIRAL 23 0.0072
179 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
180 SHOCK HAEMORRHAGIC 57 0.0070
181 LEGIONELLA INFECTION 4 0.0070
182 OPHTHALMIC HERPES SIMPLEX 4 0.0069
183 LUNG OPACITY 18 0.0068
184 SARS-COV-2 TEST POSITIVE 90 0.0068
185 ENDOTRACHEAL INTUBATION 19 0.0068
186 PNEUMOCYSTIS JIROVECII INFECTION 8 0.0067
187 ABDOMINAL WALL HAEMATOMA 13 0.0067
188 VIRAL MUTATION IDENTIFIED 24 0.0065
189 TRACHEOBRONCHITIS 5 0.0065
190 RECALLED PRODUCT ADMINISTERED 62 0.0065
191 CRITICAL ILLNESS 5 0.0064
192 MICROANGIOPATHY 6 0.0064
193 SEPTIC SHOCK 277 0.0064
194 HAEMODIALYSIS 53 0.0063
195 OXYGEN CONSUMPTION INCREASED 15 0.0063
196 BRONCHOPULMONARY DYSPLASIA 5 0.0062
197 STAPHYLOCOCCAL BACTERAEMIA 27 0.0062
198 ENDOCARDITIS 31 0.0060
199 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 327 0.0060
200 PNEUMOPERITONEUM 11 0.0059
201 PRODUCT PREPARATION ISSUE 39 0.0059
202 HEPATITIS B DNA INCREASED 4 0.0059
203 NEONATAL RESPIRATORY DISTRESS SYNDROME 21 0.0059
204 ATRIOVENTRICULAR BLOCK SECOND DEGREE 18 0.0059
205 ABSCESS NECK 4 0.0059
206 PULSE ABSENT 28 0.0059
207 COCCIDIOIDOMYCOSIS 7 0.0059
208 TRANSCRIPTION MEDICATION ERROR 9 0.0057
209 SPLENIC INFARCTION 10 0.0057
210 MENINGITIS CRYPTOCOCCAL 10 0.0057
211 HISTOPLASMOSIS DISSEMINATED 9 0.0057
212 ENTEROCOCCAL BACTERAEMIA 6 0.0057
213 HYPERLEUKOCYTOSIS 5 0.0056
214 INFLAMMATORY MARKER INCREASED 28 0.0056
215 STRONGYLOIDIASIS 9 0.0056
216 DISSEMINATED INTRAVASCULAR COAGULATION 78 0.0055
217 LISTERIOSIS 6 0.0054
218 EPSTEIN-BARR VIRAEMIA 6 0.0054
219 PNEUMONIA PNEUMOCOCCAL 8 0.0054
220 HYPERTHERMIA MALIGNANT 8 0.0054
221 BRAIN STEM SYNDROME 4 0.0053
222 STEROID DIABETES 8 0.0053
223 KLEBSIELLA BACTERAEMIA 5 0.0053
224 COVID-19 919 0.0052
225 CEREBRAL VENTRICLE DILATATION 6 0.0052
226 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 39 0.0052
227 FOETAL DISTRESS SYNDROME 11 0.0052
228 METHAEMOGLOBINAEMIA 12 0.0052
229 TORSADE DE POINTES 40 0.0051
230 ENDOCARDITIS BACTERIAL 4 0.0051
231 PRINZMETAL ANGINA 5 0.0050
232 EMPYEMA 10 0.0050
233 DISEASE COMPLICATION 23 0.0050
234 HYPOVOLAEMIC SHOCK 24 0.0050
235 HAEMODYNAMIC INSTABILITY 38 0.0050
236 HYPERCAPNIA 15 0.0050
237 CHRONIC RESPIRATORY FAILURE 6 0.0050
238 BLOOD CREATINE INCREASED 22 0.0050
239 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 13 0.0050
240 BLOOD CREATININE INCREASED 323 0.0049
241 CHORIORETINOPATHY 7 0.0049
242 SINUS NODE DYSFUNCTION 9 0.0049
243 PNEUMATOSIS INTESTINALIS 14 0.0049
244 LOW BIRTH WEIGHT BABY 39 0.0049
245 RENAL ABSCESS 4 0.0049
246 VASOPLEGIA SYNDROME 8 0.0049
247 OXYGEN THERAPY 8 0.0049
248 CORONAVIRUS TEST POSITIVE 5 0.0049
249 BLOOD LOSS ANAEMIA 11 0.0049
250 NEONATAL HYPOXIA 4 0.0048
251 NORMOCYTIC ANAEMIA 7 0.0048
252 WHITE MATTER LESION 6 0.0047
253 CEREBRAL VENOUS SINUS THROMBOSIS 4 0.0047
254 ORGAN FAILURE 19 0.0047
255 PSEUDOMONAL BACTERAEMIA 4 0.0047
256 IMMUNOSUPPRESSION 41 0.0046
257 URINARY TRACT OBSTRUCTION 11 0.0046
258 DRUG CLEARANCE DECREASED 6 0.0046
259 PNEUMONIA FUNGAL 18 0.0046
260 B-LYMPHOCYTE COUNT DECREASED 6 0.0044
261 ACIDOSIS 33 0.0043
262 ANGLE CLOSURE GLAUCOMA 11 0.0043
263 CYTOMEGALOVIRUS VIRAEMIA 19 0.0043
264 SHOCK 97 0.0042
265 HYPERNATRAEMIA 21 0.0042
266 CATATONIA 22 0.0042
267 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
268 ACUTE KIDNEY INJURY 630 0.0041
269 RESPIRATORY ACIDOSIS 16 0.0041
270 MULTI-ORGAN DISORDER 8 0.0041
271 LARGE INTESTINAL ULCER 11 0.0040
272 HEPATITIS FULMINANT 12 0.0040
273 BACTERAEMIA 48 0.0040
274 PUPIL FIXED 7 0.0040
275 PRODUCT PREPARATION ERROR 83 0.0040
276 GASTROINTESTINAL WALL THICKENING 6 0.0040
277 PSEUDOMONAL SEPSIS 7 0.0040
278 THERAPY CESSATION 205 0.0040
279 PNEUMOCYSTIS JIROVECII PNEUMONIA 40 0.0040
280 RENAL TUBULAR NECROSIS 39 0.0040
281 PSEUDOMONAS INFECTION 34 0.0040
282 TRANSPLANT DYSFUNCTION 7 0.0039
283 PANCREATITIS NECROTISING 9 0.0039
284 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 6 0.0039
285 COUNTERFEIT PRODUCT ADMINISTERED 5 0.0038
286 ENTHESOPATHY 6 0.0038
287 LATENT TUBERCULOSIS 8 0.0038
288 PULMONARY INFARCTION 9 0.0038
289 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 5 0.0038
290 STAPHYLOCOCCUS TEST POSITIVE 8 0.0038
291 INTRA-ABDOMINAL HAEMORRHAGE 9 0.0038
292 TACHYPNOEA 51 0.0037
293 CEREBRAL ARTERY OCCLUSION 4 0.0037
294 GALLBLADDER ENLARGEMENT 4 0.0037
295 BLOOD SODIUM INCREASED 10 0.0037
296 TOXOPLASMOSIS 4 0.0037
297 OXYGEN SATURATION DECREASED 208 0.0037
298 RESPIRATORY ALKALOSIS 6 0.0037
299 GASTRIC PERFORATION 10 0.0037
300 FOETAL DEATH 19 0.0037
301 ACINETOBACTER INFECTION 4 0.0037
302 PREMATURE BABY 109 0.0036
303 BRAIN DEATH 11 0.0036
304 HYPOGAMMAGLOBULINAEMIA 23 0.0035
305 CARBON DIOXIDE DECREASED 4 0.0035
306 CARDIAC ARREST 286 0.0035
307 CYTOMEGALOVIRUS TEST POSITIVE 6 0.0034
308 RENAL IMPAIRMENT 282 0.0034
309 PRODUCT CONTAMINATION MICROBIAL 4 0.0034
310 LIVEDO RETICULARIS 7 0.0033
311 CANDIDA SEPSIS 3 0.0033
312 PROTHROMBIN TIME PROLONGED 20 0.0033
313 INFUSION SITE SWELLING 21 0.0033
314 SUPERINFECTION 5 0.0033
315 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 11 0.0033
316 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 11 0.0033
317 ALANINE AMINOTRANSFERASE ABNORMAL 7 0.0033
318 HEPATOCELLULAR INJURY 47 0.0033
319 INTERNATIONAL NORMALISED RATIO INCREASED 94 0.0033
320 CANDIDA INFECTION 55 0.0033
321 EMBOLISM 27 0.0032
322 HEPARIN-INDUCED THROMBOCYTOPENIA 16 0.0032
323 SUPRAVENTRICULAR TACHYCARDIA 31 0.0032
324 OXYGEN SATURATION ABNORMAL 9 0.0032
325 GASTRIC ULCER PERFORATION 4 0.0032
326 PULMONARY TUBERCULOSIS 13 0.0030
327 INTERCEPTED PRODUCT DISPENSING ERROR 5 0.0030
328 LIVER INJURY 74 0.0030
329 BLOOD CULTURE POSITIVE 9 0.0030
330 METABOLIC ENCEPHALOPATHY 9 0.0030
331 LEUKOCYTOSIS 54 0.0030
332 PNEUMONIA ASPIRATION 74 0.0030
333 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 23 0.0030
334 ELECTROCARDIOGRAM QT PROLONGED 106 0.0029
335 HERPES SIMPLEX 19 0.0029
336 HEPATIC FUNCTION ABNORMAL 109 0.0029
337 ESCHERICHIA INFECTION 24 0.0029
338 DIVERTICULAR PERFORATION 6 0.0029
339 OLIGURIA 18 0.0029
340 DIALYSIS 41 0.0029
341 DEATH NEONATAL 4 0.0029
342 ACUTE HEPATIC FAILURE 39 0.0029
343 PERIPHERAL ARTERY OCCLUSION 4 0.0028
344 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
345 BLOOD ALKALINE PHOSPHATASE INCREASED 70 0.0028
346 MENINGITIS BACTERIAL 4 0.0028
347 HYPERPHOSPHATAEMIA 6 0.0028
348 BACTERIAL SEPSIS 9 0.0028
349 HYPERSEXUALITY 5 0.0027
350 LARGE INTESTINE PERFORATION 19 0.0027
351 MYASTHENIA GRAVIS CRISIS 4 0.0027
352 RESPIRATORY DISTRESS 74 0.0027
353 INFUSION SITE REACTION 8 0.0027
354 ENDOPHTHALMITIS 16 0.0027
355 STAPHYLOCOCCAL SEPSIS 13 0.0026
356 PATHOGEN RESISTANCE 24 0.0026
357 BLOOD BILIRUBIN INCREASED 71 0.0026
358 PREMATURE SEPARATION OF PLACENTA 4 0.0026
359 AORTIC VALVE INCOMPETENCE 11 0.0026
360 COAGULOPATHY 43 0.0026
361 BILIRUBIN CONJUGATED INCREASED 6 0.0026
362 OFF LABEL USE 2245 0.0026
363 MEGACOLON 4 0.0025
364 PATENT DUCTUS ARTERIOSUS 10 0.0025
365 DRUG-INDUCED LIVER INJURY 79 0.0025
366 HEPATOTOXICITY 56 0.0025
367 PULMONARY FUNCTION TEST DECREASED 11 0.0025
368 HEPATIC CYTOLYSIS 32 0.0025
369 TROPONIN INCREASED 19 0.0025
370 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
371 GUILLAIN-BARRE SYNDROME 12 0.0025
372 CEREBRAL ARTERY EMBOLISM 3 0.0025
373 HAEMATOLOGICAL INFECTION 6 0.0025
374 BLOOD UREA INCREASED 41 0.0024
375 MATERNAL EXPOSURE DURING PREGNANCY 217 0.0024
376 VENTRICULAR TACHYCARDIA 40 0.0024
377 HEART RATE DECREASED 84 0.0024
378 ATRIOVENTRICULAR BLOCK COMPLETE 16 0.0024
379 LUNG INFILTRATION 21 0.0024
380 GASTRITIS EROSIVE 11 0.0024
381 INFUSION SITE BRUISING 5 0.0023
382 PULMONARY HAEMORRHAGE 18 0.0023
383 CYTOMEGALOVIRUS INFECTION 38 0.0023
384 RESPIRATORY DISORDER 68 0.0023
385 NOSOCOMIAL INFECTION 5 0.0023
386 NECROTISING FASCIITIS 8 0.0023
387 VENTRICULAR FIBRILLATION 25 0.0022
388 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 5 0.0022
389 IRON DEFICIENCY 10 0.0022
390 KOUNIS SYNDROME 5 0.0022
391 METABOLIC ACIDOSIS 70 0.0022
392 THROMBOCYTOSIS 8 0.0022
393 EUGLYCAEMIC DIABETIC KETOACIDOSIS 9 0.0022
394 INTESTINAL ISCHAEMIA 12 0.0022
395 HEPATIC ENZYME INCREASED 148 0.0022
396 STAPHYLOCOCCAL INFECTION 71 0.0022
397 CARDIO-RESPIRATORY ARREST 90 0.0022
398 BLOOD LACTATE DEHYDROGENASE INCREASED 34 0.0021
399 REFUSAL OF TREATMENT BY PATIENT 14 0.0021
400 INFUSION SITE ERYTHEMA 18 0.0021
401 JAUNDICE NEONATAL 4 0.0021
402 EXPOSURE DURING PREGNANCY 131 0.0021
403 PRE-ECLAMPSIA 10 0.0021
404 HYPERGLYCAEMIA 76 0.0021
405 SERUM FERRITIN INCREASED 11 0.0021
406 ADRENAL DISORDER 4 0.0021
407 CYTOMEGALOVIRUS INFECTION REACTIVATION 9 0.0020
408 HYPERBILIRUBINAEMIA 21 0.0020
409 CATHETER SITE HAEMORRHAGE 5 0.0020
410 EMBOLISM VENOUS 6 0.0020
411 BRAIN ABSCESS 5 0.0020
412 CORONAVIRUS INFECTION 13 0.0020
413 PERIPHERAL ISCHAEMIA 8 0.0020
414 CHEST X-RAY ABNORMAL 6 0.0020
415 ACUTE MYOCARDIAL INFARCTION 56 0.0019
416 BLOOD LACTIC ACID INCREASED 10 0.0019
417 AMYLASE INCREASED 7 0.0019
418 HEPATIC FAILURE 57 0.0019
419 CARDIAC DYSFUNCTION 7 0.0019
420 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
421 CHOLESTASIS 36 0.0019
422 INTESTINAL PERFORATION 21 0.0019
423 INFUSION RELATED REACTION 124 0.0019
424 ACUTE MYELOID LEUKAEMIA RECURRENT 4 0.0019
425 HYPERKALAEMIA 65 0.0019
426 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
427 LYMPHOPENIA 26 0.0018
428 ENCEPHALOPATHY 45 0.0018
429 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
430 BRADYARRHYTHMIA 3 0.0018
431 GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0018
432 DRUG LEVEL INCREASED 30 0.0018
433 LYMPHOCYTE COUNT DECREASED 32 0.0018
434 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 9 0.0018
435 TEMPERATURE REGULATION DISORDER 4 0.0018
436 CARDIOPULMONARY FAILURE 7 0.0018
437 LUNG CONSOLIDATION 5 0.0018
438 PANCREATITIS ACUTE 40 0.0018
439 FOETAL EXPOSURE DURING PREGNANCY 144 0.0018
440 CHOLECYSTITIS ACUTE 10 0.0018
441 AMMONIA INCREASED 9 0.0018
442 ECCHYMOSIS 12 0.0017
443 CYTOKINE RELEASE SYNDROME 35 0.0017
444 CYTOMEGALOVIRUS COLITIS 4 0.0017
445 BLOOD CHLORIDE INCREASED 3 0.0017
446 CAROTID ARTERY STENOSIS 6 0.0017
447 THERAPY NON-RESPONDER 77 0.0017
448 HYPERTRIGLYCERIDAEMIA 10 0.0017
449 HYPERTENSIVE CRISIS 19 0.0017
450 INJECTION SITE EXTRAVASATION 21 0.0017
451 BRAIN HERNIATION 5 0.0017
452 LIVE BIRTH 14 0.0017
453 KIDNEY TRANSPLANT REJECTION 8 0.0017
454 HALLUCINATIONS, MIXED 7 0.0017
455 DIABETES INSIPIDUS 4 0.0017
456 NORMAL NEWBORN 9 0.0017
457 ADRENAL INSUFFICIENCY 20 0.0016
458 THROMBOTIC MICROANGIOPATHY 16 0.0016
459 SEPSIS 181 0.0016
460 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
461 URINE OUTPUT DECREASED 14 0.0016
462 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
463 STATUS EPILEPTICUS 18 0.0016
464 BLOOD BICARBONATE DECREASED 3 0.0016
465 HYPOTHERMIA 16 0.0016
466 DERMATOMYOSITIS 4 0.0016
467 PRODUCT CONTAMINATION PHYSICAL 4 0.0016
468 NOCARDIOSIS 4 0.0016
469 ARTERIAL THROMBOSIS 3 0.0016
470 UNRESPONSIVE TO STIMULI 40 0.0015
471 SUSPECTED OFF LABEL USE 7 0.0015
472 VASCULAR DEVICE INFECTION 7 0.0015
473 RHINOVIRUS INFECTION 6 0.0015
474 HEPATITIS TOXIC 4 0.0015
475 CARDIOGENIC SHOCK 22 0.0015
476 THROMBOSIS IN DEVICE 5 0.0015
477 ALTERED STATE OF CONSCIOUSNESS 33 0.0015
478 HOSPICE CARE 15 0.0015
479 BLOOD ALBUMIN DECREASED 12 0.0015
480 ANURIA 13 0.0015
481 AZOTAEMIA 6 0.0015
482 AREFLEXIA 4 0.0015
483 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
484 FOETAL GROWTH RESTRICTION 9 0.0015
485 CARDIAC TAMPONADE 7 0.0015
486 BLOOD PHOSPHORUS INCREASED 4 0.0015
487 ARTHRITIS BACTERIAL 6 0.0015
488 ORAL FUNGAL INFECTION 4 0.0015
489 CAESAREAN SECTION 17 0.0015
490 LEUKOPENIA 73 0.0015
491 CAPILLARY LEAK SYNDROME 3 0.0014
492 PRIAPISM 5 0.0014
493 ATELECTASIS 14 0.0014
494 BACTERIAL INFECTION 27 0.0014
495 GAMMA-GLUTAMYLTRANSFERASE INCREASED 32 0.0014
496 DRUG RESISTANCE 37 0.0014
497 STREPTOCOCCAL INFECTION 8 0.0014
498 THERAPY INTERRUPTED 102 0.0014
499 ACUTE PULMONARY OEDEMA 8 0.0014
500 ATRIOVENTRICULAR BLOCK 11 0.0014
501 DRUG INTERACTION 225 0.0014
502 FACIAL PARESIS 5 0.0014
503 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
504 HYPOTENSION 283 0.0014
505 HEART VALVE INCOMPETENCE 4 0.0014
506 PRODUCT ADMINISTRATION ERROR 28 0.0014
507 HAEMOTHORAX 4 0.0014
508 RESPIRATORY ARREST 38 0.0014
509 SUBARACHNOID HAEMORRHAGE 14 0.0014
510 GASTROINTESTINAL NECROSIS 4 0.0014
511 PULMONARY PAIN 4 0.0014
512 HYPOVOLAEMIA 8 0.0014
513 STRIDOR 4 0.0014
514 HYPOPHOSPHATAEMIA 10 0.0014
515 RESPIRATORY RATE INCREASED 12 0.0014
516 PULMONARY EMBOLISM 128 0.0013
517 BACTERIAL TEST POSITIVE 3 0.0013
518 TRANSFUSION 14 0.0013
519 BLOOD CALCIUM DECREASED 15 0.0013
520 MENTAL STATUS CHANGES 37 0.0013
521 LIVER DISORDER 59 0.0013
522 DELIRIUM 46 0.0013
523 BLOOD PRESSURE SYSTOLIC DECREASED 6 0.0013
524 CONDITION AGGRAVATED 396 0.0013
525 RENAL FUNCTION TEST ABNORMAL 6 0.0013
526 CONTRAINDICATED PRODUCT ADMINISTERED 39 0.0013
527 NEUROLEPTIC MALIGNANT SYNDROME 15 0.0013
528 RENAL FAILURE 167 0.0013
529 NEPHROPATHY TOXIC 14 0.0012
530 REBOUND EFFECT 14 0.0012
531 PREMATURE LABOUR 7 0.0012
532 ATRIAL FIBRILLATION 119 0.0012
533 RASH MACULO-PAPULAR 27 0.0012
534 SUSPECTED COVID-19 4 0.0012
535 STRESS CARDIOMYOPATHY 7 0.0012
536 PULMONARY FIBROSIS 23 0.0012
537 INTENTIONAL PRODUCT USE ISSUE 105 0.0012
538 SINUS TACHYCARDIA 17 0.0012
539 CEREBRAL INFARCTION 29 0.0012
540 DRUG ERUPTION 21 0.0012
541 WRONG PRODUCT ADMINISTERED 8 0.0012
542 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 6 0.0012
543 FAILURE TO THRIVE 6 0.0012
544 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
545 PARTIAL SEIZURES 6 0.0011
546 ERYTHEMA NODOSUM 4 0.0011
547 ORAL CANDIDIASIS 15 0.0011
548 MELAENA 25 0.0011
549 MYOCARDITIS 13 0.0011
550 PULMONARY TOXICITY 8 0.0011
551 LIVER FUNCTION TEST ABNORMAL 32 0.0011
552 ASPIRATION 12 0.0011
553 HEPATITIS 28 0.0011
554 IMMUNE THROMBOCYTOPENIA 5 0.0011
555 THERAPY PARTIAL RESPONDER 17 0.0011
556 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
557 EOSINOPHIL COUNT INCREASED 9 0.0011
558 IMMUNODEFICIENCY 16 0.0011
559 PULMONARY ALVEOLAR HAEMORRHAGE 6 0.0011
560 HYDRONEPHROSIS 8 0.0011
561 PROTEIN TOTAL DECREASED 4 0.0011
562 VENTRICULAR EXTRASYSTOLES 11 0.0011
563 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
564 LIPASE INCREASED 8 0.0010
565 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
566 STILLBIRTH 5 0.0010
567 PNEUMONIA 334 0.0010
568 HYPOALBUMINAEMIA 8 0.0010
569 ABORTION 3 0.0010
570 CYANOSIS 16 0.0010
571 PERITONITIS 21 0.0010
572 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 6 0.0010
573 BIPOLAR DISORDER 11 0.0010
574 CEREBRAL ATROPHY 4 0.0010
575 PLATELET COUNT INCREASED 13 0.0010
576 LACTIC ACIDOSIS 32 0.0010
577 TOXIC EPIDERMAL NECROLYSIS 15 0.0010
578 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
579 DECUBITUS ULCER 8 0.0010
580 DEMYELINATION 4 0.0010
581 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
582 THROMBOCYTOPENIA 109 0.0010
583 TACHYCARDIA 86 0.0010
584 HAEMATOMA 25 0.0010
585 GASTROINTESTINAL PERFORATION 4 0.0010
586 BLOOD CREATININE DECREASED 3 0.0010
587 BRAIN OEDEMA 12 0.0009
588 BLOOD PRESSURE DECREASED 63 0.0009
589 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
590 CARDIAC FAILURE CHRONIC 4 0.0009
591 ABSCESS LIMB 4 0.0009
592 WHITE BLOOD CELL COUNT INCREASED 36 0.0009
593 BLOOD CREATINE PHOSPHOKINASE INCREASED 27 0.0009
594 HYPOMAGNESAEMIA 13 0.0009
595 INTERSTITIAL LUNG DISEASE 45 0.0009
596 PYELONEPHRITIS 8 0.0009
597 PULMONARY CONGESTION 12 0.0009
598 ABDOMINAL ABSCESS 4 0.0009
599 CARDIAC FAILURE ACUTE 6 0.0009
600 APNOEA 7 0.0009
601 ISCHAEMIC STROKE 16 0.0009
602 HAEMOLYTIC ANAEMIA 8 0.0009
603 PAPILLOEDEMA 4 0.0009
604 DEATH 762 0.0009
605 NO ADVERSE EVENT 160 0.0009
606 ATRIAL FLUTTER 7 0.0009
607 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
608 PRODUCT DISPENSING ERROR 19 0.0009
609 ISCHAEMIA 4 0.0009
610 PRODUCT USE IN UNAPPROVED INDICATION 215 0.0009
611 UROSEPSIS 8 0.0009
612 HAEMATOCRIT DECREASED 17 0.0009
613 EJECTION FRACTION DECREASED 13 0.0008
614 TUMOUR MARKER INCREASED 4 0.0008
615 BODY TEMPERATURE INCREASED 17 0.0008
616 PANCREATITIS 44 0.0008
617 HEPATITIS CHOLESTATIC 5 0.0008
618 GASTROINTESTINAL HAEMORRHAGE 69 0.0008
619 CAROTID ARTERY OCCLUSION 3 0.0008
620 DISEASE RECURRENCE 39 0.0008
621 MYOPATHY 7 0.0008
622 HYPERVOLAEMIA 4 0.0008
623 CHOLANGITIS 5 0.0008
624 SMALL FOR DATES BABY 4 0.0008
625 DISEASE PROGRESSION 95 0.0008
626 BLOOD POTASSIUM INCREASED 13 0.0008
627 C-REACTIVE PROTEIN INCREASED 29 0.0008
628 RHABDOMYOLYSIS 33 0.0008
629 INFUSION SITE PAIN 10 0.0008
630 ELECTROLYTE IMBALANCE 9 0.0008
631 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
632 DEEP VEIN THROMBOSIS 50 0.0008
633 HEPATITIS ACUTE 5 0.0008
634 RETINAL DETACHMENT 7 0.0008
635 DEPRESSED LEVEL OF CONSCIOUSNESS 30 0.0008
636 MENINGITIS 5 0.0007
637 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
638 PULMONARY THROMBOSIS 8 0.0007
639 INFARCTION 5 0.0007
640 PHARYNGEAL SWELLING 7 0.0007
641 MALNUTRITION 8 0.0007
642 PULMONARY OEDEMA 32 0.0007
643 HEPATOMEGALY 7 0.0007
644 BUNDLE BRANCH BLOCK LEFT 3 0.0007
645 MITRAL VALVE INCOMPETENCE 8 0.0007
646 BRONCHOSPASM 10 0.0007
647 PARALYSIS 10 0.0007
648 BRAIN INJURY 7 0.0007
649 TOXIC SKIN ERUPTION 7 0.0007
650 EMPHYSEMA 7 0.0007
651 FLUID OVERLOAD 10 0.0007
652 EOSINOPHILIA 12 0.0007
653 NEUTROPHIL COUNT INCREASED 7 0.0007
654 HAEMOPTYSIS 19 0.0007
655 PRODUCT USE ISSUE 128 0.0007
656 CARDIOTOXICITY 6 0.0007
657 HEPATITIS B 4 0.0007
658 PNEUMONITIS 18 0.0007
659 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
660 CIRCULATORY COLLAPSE 11 0.0006
661 PARANOIA 11 0.0006
662 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
663 HEART RATE IRREGULAR 14 0.0006
664 CARDIOMYOPATHY 9 0.0006
665 BREATH SOUNDS ABNORMAL 3 0.0006
666 MANIA 10 0.0006
667 ABDOMINAL TENDERNESS 3 0.0006
668 HEMIPLEGIA 5 0.0006
669 FUNGAL INFECTION 20 0.0006
670 AGITATION 44 0.0006
671 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
672 RED BLOOD CELL COUNT DECREASED 17 0.0006
673 PRODUCT LABEL ISSUE 4 0.0006
674 NEUTROPHIL COUNT DECREASED 24 0.0006
675 CHILLS 69 0.0006
676 HYPERLIPIDAEMIA 7 0.0006
677 POLYNEUROPATHY 7 0.0006
678 HAEMOGLOBIN DECREASED 60 0.0006
679 DRUG INEFFECTIVE 768 0.0006
680 RESPIRATION ABNORMAL 4 0.0006
681 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
682 EXTRASYSTOLES 4 0.0006
683 INTERCEPTED PRODUCT PREPARATION ERROR 7 0.0006
684 HYPERCALCAEMIA 7 0.0006
685 CEREBRAL HAEMORRHAGE 20 0.0006
686 ANAL ABSCESS 3 0.0006
687 MOUTH HAEMORRHAGE 4 0.0005
688 HEPATIC STEATOSIS 10 0.0005
689 PLATELET COUNT DECREASED 57 0.0005
690 PYREXIA 185 0.0005
691 LUNG DISORDER 26 0.0005
692 COMA 25 0.0005
693 CARDIAC FAILURE 42 0.0005
694 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
695 HAEMORRHAGIC STROKE 4 0.0005
696 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
697 ANAPHYLACTIC SHOCK 13 0.0005
698 CHOLECYSTITIS 6 0.0005
699 BLOOD DISORDER 4 0.0005
700 HYPOKALAEMIA 23 0.0005
701 MYASTHENIA GRAVIS 4 0.0005
702 PLEURAL EFFUSION 30 0.0005
703 ASPHYXIA 4 0.0005
704 HICCUPS 4 0.0005
705 GENERALISED OEDEMA 6 0.0005
706 AGRANULOCYTOSIS 9 0.0005
707 ACUTE CORONARY SYNDROME 4 0.0005
708 RASH ERYTHEMATOUS 23 0.0005
709 NEUTROPENIA 65 0.0005
710 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 14 0.0005
711 ANAPHYLACTIC REACTION 26 0.0005
712 HYPOPHAGIA 12 0.0005
713 LETHARGY 27 0.0005
714 CARDIAC FLUTTER 3 0.0005
715 ORAL HERPES 9 0.0005
716 DIABETIC KETOACIDOSIS 11 0.0005
717 DYSPNOEA 259 0.0005
718 NEUROTOXICITY 8 0.0005
719 DEVICE RELATED INFECTION 7 0.0005
720 TUMOUR LYSIS SYNDROME 4 0.0005
721 MEDICATION ERROR 25 0.0004
722 BRONCHIECTASIS 3 0.0004
723 OSTEOMYELITIS 8 0.0004
724 HALLUCINATION, AUDITORY 7 0.0004
725 MYOCARDIAL ISCHAEMIA 5 0.0004
726 THROMBOSIS 35 0.0004
727 DIVERTICULITIS 12 0.0004
728 PULMONARY HYPERTENSION 9 0.0004
729 POST PROCEDURAL HAEMORRHAGE 5 0.0004
730 ANGIOEDEMA 19 0.0004
731 RENAL DISORDER 20 0.0004
732 VASCULITIS 5 0.0004
733 NEPHROPATHY 4 0.0004
734 CHOLELITHIASIS 14 0.0004
735 FLANK PAIN 4 0.0004
736 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
737 PRODUCT STORAGE ERROR 37 0.0004
738 FEBRILE NEUTROPENIA 28 0.0004
739 SUBDURAL HAEMATOMA 6 0.0004
740 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
741 SEIZURE 48 0.0004
742 HAEMATURIA 14 0.0004
743 CYTOPENIA 5 0.0004
744 RESPIRATORY DEPRESSION 5 0.0004
745 MUSCLE SPASTICITY 5 0.0004
746 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
747 WHEEZING 24 0.0004
748 RENAL INJURY 12 0.0004
749 ARRHYTHMIA 19 0.0004
750 OSTEONECROSIS 13 0.0004
751 CARDIOVASCULAR DISORDER 10 0.0004
752 BLINDNESS 16 0.0004
753 ACUTE MYELOID LEUKAEMIA 6 0.0004
754 HYPERTENSION 81 0.0004
755 HYPERHIDROSIS 49 0.0004
756 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
757 SUDDEN DEATH 4 0.0004
758 PRODUCT PRESCRIBING ERROR 9 0.0004
759 ASCITES 11 0.0004
760 HEPATIC CIRRHOSIS 7 0.0004
761 NEURALGIA 9 0.0004
762 INFECTION 53 0.0004
763 APHASIA 11 0.0004
764 STEVENS-JOHNSON SYNDROME 8 0.0004
765 SKIN INFECTION 4 0.0004
766 ANAEMIA 68 0.0004
767 HAEMATEMESIS 9 0.0004
768 HEMIPARESIS 6 0.0004
769 HYPOGLYCAEMIA 17 0.0004
770 INTERNAL HAEMORRHAGE 4 0.0003
771 BONE MARROW FAILURE 7 0.0003
772 FLUSHING 35 0.0003
773 LABORATORY TEST ABNORMAL 10 0.0003
774 PSYCHOTIC DISORDER 10 0.0003
775 PULMONARY MASS 5 0.0003
776 BLOOD PRESSURE FLUCTUATION 8 0.0003
777 TREATMENT FAILURE 27 0.0003
778 CHEST PAIN 60 0.0003
779 LYMPHOMA 5 0.0003
780 DERMATITIS ALLERGIC 4 0.0003
781 ABSCESS 5 0.0003
782 SEROTONIN SYNDROME 6 0.0003
783 RASH PAPULAR 7 0.0003
784 AFFECT LABILITY 3 0.0003
785 SENSORY DISTURBANCE 5 0.0003
786 TREMOR 51 0.0003
787 URINARY TRACT INFECTION 52 0.0003
788 PANCYTOPENIA 17 0.0003
789 BLISTER 17 0.0003
790 BLOOD PRESSURE ABNORMAL 6 0.0003
791 DIABETES MELLITUS 23 0.0003
792 CEREBROVASCULAR ACCIDENT 51 0.0003
793 BLOOD POTASSIUM DECREASED 9 0.0003
794 EXTRA DOSE ADMINISTERED 12 0.0003
795 RASH PRURITIC 16 0.0003
796 PALLOR 8 0.0003
797 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
798 SWELLING 27 0.0003
799 MOUTH ULCERATION 6 0.0003
800 DYSPHAGIA 27 0.0003
801 BLINDNESS UNILATERAL 4 0.0003
802 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
803 COUGH 79 0.0003
804 THERAPEUTIC RESPONSE DECREASED 17 0.0003
805 OEDEMA 15 0.0003
806 END STAGE RENAL DISEASE 5 0.0003
807 HEART RATE INCREASED 27 0.0003
808 SEDATION 7 0.0003
809 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
810 HYPONATRAEMIA 15 0.0003
811 HYPOAESTHESIA ORAL 4 0.0003
812 PROTEINURIA 5 0.0003
813 HYPERSENSITIVITY 48 0.0003
814 DELUSION 4 0.0003
815 RASH MACULAR 9 0.0003
816 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
817 HAEMORRHAGE 26 0.0002
818 FULL BLOOD COUNT DECREASED 5 0.0002
819 PRESYNCOPE 6 0.0002
820 CHEST DISCOMFORT 25 0.0002
821 CARDIOMEGALY 3 0.0002
822 BURNING SENSATION 17 0.0002
823 EXPIRED PRODUCT ADMINISTERED 8 0.0002
824 DYSARTHRIA 9 0.0002
825 ERYTHEMA 49 0.0002
826 HAEMATOCHEZIA 13 0.0002
827 RESPIRATORY TRACT INFECTION 6 0.0002
828 SYNCOPE 23 0.0002
829 FEELING HOT 14 0.0002
830 COLD SWEAT 4 0.0002
831 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
832 LYMPHADENOPATHY 8 0.0002
833 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
834 JAUNDICE 6 0.0002
835 THROAT TIGHTNESS 6 0.0002
836 CHROMATURIA 5 0.0002
837 TOXICITY TO VARIOUS AGENTS 37 0.0002
838 DEHYDRATION 29 0.0002
839 UPPER RESPIRATORY TRACT INFECTION 10 0.0002
840 PERICARDIAL EFFUSION 5 0.0002
841 RASH 94 0.0002
842 DISCOMFORT 13 0.0002
843 BLOOD SODIUM DECREASED 4 0.0002
844 COLITIS 8 0.0002
845 CONFUSIONAL STATE 34 0.0002
846 LIP SWELLING 7 0.0002
847 URINARY RETENTION 7 0.0002
848 PRODUCTIVE COUGH 10 0.0002
849 ANOSMIA 3 0.0002
850 TREATMENT NONCOMPLIANCE 11 0.0002
851 ABORTION SPONTANEOUS 8 0.0002
852 FEEDING DISORDER 4 0.0002
853 MYELOSUPPRESSION 7 0.0002
854 INCORRECT DOSE ADMINISTERED 44 0.0002
855 DYSURIA 7 0.0002
856 FAECES DISCOLOURED 4 0.0002
857 SWELLING FACE 12 0.0002
858 SOMNOLENCE 37 0.0002
859 PRODUCT PRESCRIBING ISSUE 4 0.0002
860 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
861 BLOOD GLUCOSE INCREASED 34 0.0002
862 TYPE 2 DIABETES MELLITUS 6 0.0002
863 ASTHENIA 67 0.0002
864 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
865 ILLNESS 18 0.0002
866 URTICARIA 29 0.0002
867 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
868 LACRIMATION INCREASED 5 0.0002
869 BONE DISORDER 3 0.0002
870 RESTLESSNESS 6 0.0002
871 EPILEPSY 5 0.0002
872 EYE SWELLING 6 0.0002
873 MENTAL DISORDER 7 0.0002
874 EPISTAXIS 12 0.0002
875 NERVOUS SYSTEM DISORDER 5 0.0002
876 UNEVALUABLE EVENT 12 0.0002
877 HEAD INJURY 5 0.0002
878 CHRONIC KIDNEY DISEASE 12 0.0002
879 NEUROPATHY PERIPHERAL 15 0.0002
880 CYSTITIS 5 0.0002
881 THROAT IRRITATION 7 0.0002
882 INFLAMMATION 8 0.0002
883 ANXIETY 44 0.0002
884 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
885 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
886 ABDOMINAL DISTENSION 16 0.0002
887 VOMITING 72 0.0002
888 SKIN DISCOLOURATION 7 0.0002
889 IMPAIRED HEALING 5 0.0002
890 BLOOD PRESSURE INCREASED 23 0.0002
891 PERIPHERAL SWELLING 23 0.0001
892 PAIN OF SKIN 4 0.0001
893 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
894 DECREASED APPETITE 34 0.0001
895 POLLAKIURIA 6 0.0001
896 NEOPLASM PROGRESSION 5 0.0001
897 WOUND 4 0.0001
898 INTENTIONAL DOSE OMISSION 4 0.0001
899 RECTAL HAEMORRHAGE 6 0.0001
900 CARDIAC DISORDER 13 0.0001
901 CELLULITIS 7 0.0001
902 PRODUCT DOSE OMISSION 9 0.0001
903 ABDOMINAL PAIN 32 0.0001
904 OVERDOSE 29 0.0001
905 DYSPNOEA EXERTIONAL 5 0.0001
906 NAUSEA 105 0.0001
907 NEPHROLITHIASIS 6 0.0001
908 TINNITUS 6 0.0001
909 DIARRHOEA 84 0.0001
910 DISTURBANCE IN ATTENTION 7 0.0001
911 SWOLLEN TONGUE 4 0.0001
912 ARTHRITIS 10 0.0001
913 DISORIENTATION 5 0.0001
914 LUNG NEOPLASM MALIGNANT 5 0.0001
915 EYE IRRITATION 7 0.0001
916 MALAISE 53 0.0001
917 AGEUSIA 3 0.0001
918 PRURITUS 46 0.0001
919 HALLUCINATION 9 0.0001
920 OROPHARYNGEAL PAIN 11 0.0001
921 MYOCARDIAL INFARCTION 20 0.0001
922 INTENTIONAL PRODUCT MISUSE 10 0.0001
923 DRUG INTOLERANCE 11 0.0001
924 PALPITATIONS 13 0.0001
925 ACCIDENTAL OVERDOSE 4 0.0001
926 LOSS OF CONSCIOUSNESS 14 0.0001
927 ABNORMAL DREAMS 3 0.0001
928 COGNITIVE DISORDER 5 0.0001
929 BLOOD GLUCOSE DECREASED 5 0.0001
930 ILL-DEFINED DISORDER 6 0.0001
931 DYSKINESIA 4 0.0001
932 DIZZINESS 49 0.0001
933 PAIN 60 0.0001
934 CONSTIPATION 21 0.0001
935 FALL 32 0.0001
936 FEELING ABNORMAL 23 0.0001
937 BACK PAIN 22 0.0001
938 BRONCHITIS 7 0.0001
939 ABDOMINAL PAIN UPPER 19 0.0001
940 HEADACHE 56 0.0001
941 EYE PAIN 5 0.0001
942 MYALGIA 15 0.0001
943 MUSCULAR WEAKNESS 10 0.0001
944 CARDIAC FAILURE CONGESTIVE 7 0.0001
945 HERPES ZOSTER 5 0.0001
946 MULTIPLE SCLEROSIS 4 0.0001
947 STOMATITIS 5 0.0001
948 OEDEMA PERIPHERAL 10 0.0001
949 FATIGUE 61 0.0001
950 SINUSITIS 8 0.0001
951 AMNESIA 5 0.0001
952 SUICIDAL IDEATION 7 0.0001
953 ALOPECIA 15 0.0001
954 PARAESTHESIA 12 0.0001
955 PRODUCT DOSE OMISSION ISSUE 22 0.0001
956 CONTUSION 7 0.0001
957 DEVICE MALFUNCTION 5 0.0001
958 SLEEP DISORDER 5 0.0001
959 BALANCE DISORDER 6 0.0001
960 UNDERDOSE 5 0.0001
961 NASAL CONGESTION 4 0.0001
962 DYSGEUSIA 5 0.0001
963 ADVERSE DRUG REACTION 6 0.0001
964 VERTIGO 4 0.0001
965 VISION BLURRED 9 0.0001
966 ADVERSE EVENT 6 0.0001
967 HOSPITALISATION 10 0.0001
968 INSOMNIA 16 0.0001
969 MUSCLE SPASMS 11 0.0001
970 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
971 INJURY 4 0.0001
972 ARTHRALGIA 23 0.0001
973 PAIN IN EXTREMITY 16 0.0001
974 WEIGHT DECREASED 15 0.0001
975 HYPOAESTHESIA 8 0.0001
976 GAIT DISTURBANCE 10 0.0001
977 INFLUENZA LIKE ILLNESS 4 0.0000
978 DEPRESSION 11 0.0000
979 INFLUENZA 5 0.0000
980 GASTROINTESTINAL DISORDER 4 0.0000
981 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 9 0.0000
982 MEMORY IMPAIRMENT 6 0.0000
983 NASOPHARYNGITIS 8 0.0000
984 MIGRAINE 4 0.0000
985 EMOTIONAL DISTRESS 5 0.0000
986 ASTHMA 4 0.0000
987 INJECTION SITE ERYTHEMA 4 0.0000
988 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
989 ABDOMINAL DISCOMFORT 4 0.0000
990 INJECTION SITE PAIN 4 0.0000